This is a call to past, present and potential NIH Fellows, Fogarty trainees-anyone with a link to the NIH who comes from South Africa and/or other African countries-to contact me.
The FIC has given the MRC pilot funding to see whether an 'NIH Alumni Association' would be of value to you. I would like to hear from you if you are interested in being a member of a potential South African/Southern African/Sub-Saharan African/… association. Or, if you don't want to be a member but could be a point of contact for advice/networking/involving the Diaspora, I would also like to hear from you.
That's what we need to find out from you. Click the links numbered topics below for some ideas from other South Africans to start with:
1) Mentoring, teaching, visiting staff
Alumni as co-supervisors of postgraduate degrees, especially of staff members where there is a lack of specialists in specific research areas
Alumni giving courses/talks on research skills
Alumni presenting lectures and courses to staff and postgraduates
Build capacity within African universities by assessing the environment of researchers with potential and funding not just their research/exchange/sabbatical/training/etc but also someone to take over their teaching load
Linking South African institutions with gaps in research capacity with academic institutions possessing the needed capacity
2) Technical support: workshops / training in grants processes
Training of SA researchers in:
Report writing (also perhaps train finance/administrative staff in budget reporting)
Standard operating procedures outlining requirements of institution and of PI with respect to the funding agency
Training in grants management and grant writing
Exposure of researchers to the NIH system of evaluation: the working group structure, how to write the proposal so that it will be viewed by a working group whose members are experts in and sympathetic to the area of research being proposed
Investigate the possibility of allowing researchers the freedom to add new themes to research proposals, after approval has been given for the initial proposal
3) Work with the SA Diaspora
co-operation with grant-writing
introduction to funding opportunities
networking SA researchers with other researchers in their field
6-12-month sabbaticals (or grants supporting a re-integration period) for scientists returning from the USA, with resources available for:
The postdoc who returns with a project and is able to hit the ground running
The postdoc who cannot bring a project home with them, needs support, startup funding, more institutional support (approach MRC or group of supportive researchers, get funding for 6-month visit to start project, write grant application, start exchanges)
Inter-university movement: to allow researchers in institutions which focus more on teaching to move to a more research-oriented institution (or partner with one)
Locate US students/researchers who could come to work in an SA environment (3-4 years to do a PhD here, or 1-2 years postdoc)
5) Association's Web, database and people
Web page where researchers can:
Find an interface which facilitates their introduction to the who, how, when, where and what of NIH
Locate and access mentors/advisers and other researchers in their field via a database
Add their details to the database
Other possible initiatives:
gatherings: a culture of reunions, e.g. piggyback on PHASA meetings, AIDS conferences
regular information: quarterly newsletters, need commitment from, for e.g., ex trainees
sustaining the researcher base: making training opportunities known to the wider research community, opening to wider audience
Other needs of the association:
A steering committee, terms of reference
6) National and institutional capacity development
Development of an individual (or more) per institution who knows NIH and its processes and people well and can advise and support colleagues writing proposals (possibly a mid-level scientist who is on a research committee)
If an association is to be formed, it will only be because you want it and will sustain it. We could use the pilot funding for you to hold initial meetings or workshops for association planning purposes.
Please contact me with your ideas, using the online form.
I look forward to corresponding with you and assisting you with setting up your NIH Alumni Association.
Office of International Affairs
South African Medical Research Council
MRC researchers, before applying for external funding, please submit all proposals to the Project Office, for the attention of Pierre Boshoff.
The National Institutes of Health (NIH)
United States of America
The NIH is the primary federal agency, in the United States of America, for funding and performing medical research.
Please note the NIH Grants Policy Statement (10/98): If you are intending to apply for NIH funding, you might like to start by looking at their Grants Policy Statement which includes a description of their policy on awards to foreign institutions, international organizations, and domestic grants with substantial foreign components. See http://grants.nih.gov/grants/policy/policy.htm
NIH funding opportunities and notices
(Suggestion: scroll down to the 'Weekly Issue of the NIH Guide for Grants and Contracts' where you can read each week's list of new announcements, or subscribe to a listserv which will email them to you each week.) You need to check the eligibility requirements for these announcements, as not all are open to non-US applicants.
Centers for Disease Control and Prevention (CDC)
United States of America
The Centers for Disease Control and Prevention (CDC) serves as the national focus for developing and applying disease prevention and control, environmental health, and health promotion and health education activities designed to improve the health of the people of the United States.
The Wellcome Trust is an independent charity funding research to improve human and animal health. Established in 1936 and with an endowment of around £13 billion, it is the UK's largest non-governmental source of funds for biomedical research.
Please see the Trust’s international page for further information about funding opportunities.
European Commission, Framework Programme 7
(FP7) European Union
For guidelines on what is possible with the FP7, please visit the webpage of the European South Africa Science and Technology Advancement Programme (ESASTAP). South Africa and the European Union enjoy a privileged partnership marked by longstanding political, economic and development cooperation ties. The first intergovernmental agreement ever concluded between South Africa and the European Union, the Agreement on Science and Technology Cooperation signed in 1996, afforded South African researchers the opportunity to participate fully in the EU's Framework Programmes for Research and Technology Development. ESASTAP, a Specific Support Action, implemented by the South African Department of Science and Technology (DST) and funded by the European Commission (EC) under the Sixth Framework Programme (FP6), will significantly enhance the support and assistance available to both South African and European researchers to optimally leverage mutual benefits from this partnership. You will find information on searching for collaborating partners, mobility (SA to Europe and vice versa) funding, seed funding for building the early stages of collaborations, and how to access research funding.
European and Developing Countries Clinical Trials Partnership (EDCTP) European Union
The European & Developing Countries Clinical Trials Partnership (EDCTP) was created in 2003 as a European response to the global health crisis caused by the three main poverty-related diseases of HIV/AIDS, malaria and tuberculosis. These diseases account for over 6 million deaths each year, and the numbers are growing. Sub-Saharan Africa is the world's worst-affected region where besides ravaging lives, they impede development and cause poverty.
Special Programme for Research and Training in Tropical Diseases
(TDR) World Health Organisation
TDR funds specific research projects in diseases of poverty, which cover infectious diseases and the culture and environment that contribute to these problems. It also supports the development of individuals and institutions in the countries where these diseases are prevalent.
TWAS is an autonomous international organization, based in Trieste, Italy, that promotes scientific excellence for sustainable development in the South. Originally named "Third World Academy of Sciences", it was founded in 1983 by a distinguished group of scientists from the South under the leadership of the late Nobel laureate Abdus Salam of Pakistan. The Academy's strength resides in the quality and diversity of its membership - internationally renowned scientists elected by their peers.
The objective of the National Research Foundation (NRF) is to support and promote research in South Africa through funding, human resource development and the provision of the necessary research facilities, in order to facilitate the creation of knowledge, innovation and development in all fields of the natural and social sciences, humanities and technology.
Comments and Submissions:
The content of this page is maintained by the MRC's Office of International Affairs. If you have any comments or wish to have your funding opportunity, training opportunity, meeting (workshops, conferences, symposia, etc.) listed here, please contact firstname.lastname@example.org. The MRC reserves the right to decide what gets published.
ESASTAP additional support for SA researchers who participate in FP7 programmes
The Department of Science and Technology is committed to promoting and supporting South African participation in the European Union funding programmes and in bilateral collaborations with European researchers. As such, we have evaluated the instruments established to support SA-EU partnerships with the aim of improving our service to the broader South African research community. We have thus, in preparation for Horizon 2020 and South African participation in the remaining FP7 calls, made provision for FP7 co-investment funding to include cover for some of the research costs and researcher's time working on FP7 funded projects.
ESASTAP is a Specific Support Action implemented by the South African Department of Science and Technology and supported by the European Commission under the Seventh Framework Programme; email@example.com, 012 843 6341 / 6338.
Chevening Scholarship Programme
Applications invited for Chevening Scholarship Programme from Young Professionals in Select African Countries to pursue PG studies in the UK British Council is currently seeking applications for the Chevening Scholarship Programme from young eligible and outstanding professionals in select African countries viz. Botswana, Nigeria, Ethiopia, South Africa, South Sudan, Uganda, and Zambia who are already experienced in their chosen profession and would like to further develop their career with a postgraduate course in the UK.
The Chevening Scholarship Programme is a prestigious awards scheme that funds international postgraduate students who want to study in the UK for one academic year.
Funded by the UK’s Foreign and Commonwealth Office and administered by the British Council, the scheme operates in over 150 countries and annually provides funding for over 2,300 scholars.
Fields of Study: Economics, Finance, Banking, Law, Human rights, Public administration, Management, Project planning, Media, Political science, International relations, Diplomatic training, Environmental studies, although applicants for other courses (as varied as counter-terrorism, religion and energy/climate change) may be considered.
You are expected to show a commitment to return to your country, where you will contribute to the country’s socio-economic development using the new skills and knowledge acquired during your stay in the UK.
Eligibility - you can apply for a Chevening scholarship if:
You are a postgraduate student who can prove your academic success and who has already begun a career in your chosen field.
You have between two and five years working experience (depending on the country you are applying in), with an excellent track record illustrating your achievements and your potential to use the skills gained during your scholarship to make a difference in your country.
You have achieved an excellent mark for you undergraduate degree and can provide a transcript of your academic record. Specific academic requirements are available from the British Council offices in your country.
You are 21 years or older (there are upper age limits for specific countries so please ensure you check this during your applications process).
You are a resident in your country when you apply and provide your birth certificate (with translation).
You must have good English language skills (most UK Higher Education institutions require a minimum IELTS of 6.5 for admission into postgraduate courses).
Application Deadlines: Applications are only open at certain times of the year and differ per country.
From 1 April 2012, the British Council ceased to be the administrator of the Chevening Scholarships programme and will no longer be able to deal with Chevening enquiries. The FCO and the Association Commonwealth Universities (ACU) have set up an email contact point for the management of 2013/14 Chevening application process. For all enquiries please contact firstname.lastname@example.org – the new email gateway for Chevening enquiries. Those existing candidates who have been. provisionally selected as a Chevening Scholar for the 2012/2013 academic year will be contacted by the new administrator. For more information please refer to: The Chevening Scholarships Secretariat at the ACU Further information can also be found here
Global Infectious Disease Research Training Program
Global Infectious Disease Research Training Program (D43) (PAR-10-260)
Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-10-262)
Letters of Intent Receipt Dates: October 2, 2010; April 21, 2012; April 21, 2013
Application Due Dates: November 2, 2010; May 21, 2012; May 21, 2013
Eligibility for Global Infectious Disease Research Training Program (D43)
U.S. Institutions with a demonstrated collaboration with a researcher in low- and middle-income country (LMIC) institutions may apply.
Foreign institutions in LMICs may also apply.
Applicant institution must have active, ongoing research (18 months of funding remaining at the time of applicant submission).
Eligibility for Planning Grant for Global Infectious Disease Research Training Program (D71)
Applicants may only be submitted by foreign institutions in LMICs, as defined by the World Bank Classification system.
Foreign applicants should apply in collaboration with U.S. institutions and must name an individual in the proposed institution as the major collaborator.
Applicant institutions for both the full institutional grant and the planning grant may submit more than one application, provided that each application is scientifically distinct.
Program Overview: Fogarty developed this program to address research training needs related to infectious diseases that are predominantly endemic in or impact upon people living in developing countries. The training programs include a variety of research training options to match the needs of the developing country institution. The ultimate goal is to build a critical mass of researchers and support staff to conduct independent infectious disease research in developing country institutions.
Training programs could include:
Long-term (master’s or doctoral degree and other training that is six months or longer) training for the full range of skills necessary to support research and research administration with the understanding that the focus of thesis and training-related research will be in their country.
Medium-term (three- to up to six-months) training or mentoring, including specialized clinical, laboratory, research or administrative/business skills necessary to support research that is planned or ongoing.
Short-term (less than three months) training or mentoring that focuses on research methodology, laboratory skills necessary to support research ethics and compliance issues, program and grants administration and financial management, grant writing, preparation of scientific manuscripts, data management, informatics, and other relevant areas.
Institutional capacity-building efforts such as in-country training workshops in advanced research techniques, distance learning and informatics.
Advanced in-country mentored research undertaken by the trainee in his/her home country upon completion of his/her initial period of long-term training under the program.
Claude Leon Foundation Postdoctoral Fellowships
The Claude Leon Foundation announces the 2014 round of the postdoctoral fellowship programme in the sciences at South African universities. The main goal is the building of research capacity at all South African universities and research institutes. The postdoctoral fellowships commencing in 2014 are for research in the faculties of Science, Engineering and Medical Sciences to be conducted at universities and some institutes in South Africa. The fellowship will be awarded for two years and will be worth R185 000 per annum. The fellowships are open to South African and foreign nationals.
2013 EDCTP Awards to Outstanding African Scientists now open to nominations
The European & Developing Countries Clinical Trials Partnership (EDCTP) invites nominations for the 2013 Awards to Outstanding African Scientist. The awards will recognise an African Outstanding Scientist and a Rising Star (scientists = 45 years of age) working on HIV/AIDS, tuberculosis and malaria in the scope of the EDCTP programme. The awards will be extended at the Seventh EDCTP Forum in Dakar, Senegal on 24 October 2013.
The Rising Star Award recognises mid-career researchers who have made significant achievements in their field and who will continue to become leaders in their research field.
The Outstanding Scientist Award is for senior researchers who have made outstanding achievements in their field and who are recognised as research leaders in Africa. In addition to their scientific excellence, the awardees will have made major contributions to the EDCTP objectives of strengthening clinical research capacity in Africa and supporting South-South and North-South networking.
Awards: Each award consists of a recognition trophy together with a cash prize of 10,000 Euros for the Rising Star award and 20,000 Euros for the Outstanding Scientist award. These awards will further the research programmes of the winners and may support activities such as study visits and training attachments to collaborating institutions, data collection for baseline studies, conference and meeting attendance, and other relevant research-related activities.
Eligibility: The awards are open to scientists from sub-Saharan Africa working in HIV/AIDS, tuberculosis and malaria within the scope of the EDCTP programme. Nominees should be scientists from sub-Saharan Africa who have spent the majority of their careers based in Africa. The Rising Star nominee must be = 45 years of age at the time of award on 24 October 2013.
Please note that a maximum of one nomination per award category will be accepted from the nominator.
More information: For more information please visit the EDCTP awards page on the Seventh EDCTP Forum website.
Basic Cancer Research in Cancer Health Disparities (U01)
FOA Purpose Through this Funding Opportunity Announcement (FOA), the Center to Reduce Cancer Health Disparities (CRCHD), the Division of Cancer Biology (DCB) and Division of Cancer Prevention (DCP), at the National Cancer Institute (NCI), encourage grant applications from investigators interested in conducting basic, mechanistic research into the biologic/genetic causes of cancer health disparities. These cooperative agreement research awards (U01) will support innovative studies designed to investigate biological/genetic bases of cancer disparities, and may include the development and testing of new methodologies and models, secondary data analyses, and mechanistic studies of identified biological factors associated with cancer disparities, including those related to basic research in prevention strategies. This FOA is also
designed to aid and facilitate the development of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can develop resources and tools, such as biospecimens, cell lines and methods that are necessary to conduct basic research in cancer health disparities.
Eligibility of Foreign Institutions:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Open Date (Earliest Submission Date) May 20, 2012
Letter of Intent Due Date Not Applicable
Application Due Date(s) June 20, 2012; November 20, 2012; June 20, 2013; November 20, 2013; June 20, 2014; November 20, 2014 , by 5:00 PM local time of applicant organization.
Earliest Start Date(s) April 2013, July 2013, April 2014, July 2014, April 2015, July 2015
Fogarty HIV Research Training Program
The Fogarty HIV Research Training Program solicits applications under three different Funding Opportunities Announcements (FOAs):
Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D43, PAR-12-068)
Limited Competition: Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71, PAR-12-070)
Training Programs for Critical HIV Research Infrastructure for Low- and Middle-Income Country Institutions (G11, PAR-12-069)
The overall goal of the Fogarty HIV Research Training Program is to strengthen the human capacity to contribute to the ability of institutions in low- and middle-income countries (LMIC) to conduct HIV-related research on the evolving HIV-related epidemics in their country and to compete independently for research funding. middle-income economies.)
Letter of Intent Due Dates: 24 June 2012; 24 June 2013; 24 June 2014
Application Due Dates: 24 July 2012; 24 July 2013; 24 July 2014
Important information on the upcoming European Research Council calls: what's new?
A number of changes are envisaged in the upcoming European Research Council (ERC) calls for proposals, of which some are important to note in advance for potential applicants.
Please note that at this stage the information below is indicative only. This is expected to be formally confirmed on 9 July 2012, when the European Commission is expected to adopt the ERC's next work programme. Only the information that will be published on the Participant Portal should be considered official.
The main changes include:
The introduction of the "ERC Consolidator grant": The previous ERC Starting grant scheme will be divided into two separate calls:
Starting grant (StG): for researchers who have been awarded their first PhD at least 2 and up to 7 years prior to the publication date of the call.
Consolidator grant (CoG): for researchers who have been awarded their first PhD over 7 and up to 12 years prior to the publication date of the call.
A Consolidator grant is worth up to €2 million (under certain circumstances up to €2.75 million).
One single deadline for each call, and not different deadlines for the three domains as in the past.
The publication of the next Advanced grant (AdG) call will be on 10 July (not in the autumn as previously), with the deadline for applications in the autumn (not in spring as in the past).
In sum, the planned publication dates and deadlines for all upcoming calls are as follows:
Starting Grant (ERC-2013-StG)
10 July 2012
17 October 2012
Advanced Grant (ERC-2013-AdG)
10 July 2012
22 November 2012
Synergy Grant (ERC-2013-SyG)
10 October 2012
10 January 2013
Consolidator Grant (ERC-2013-CoG)
7 November 2012
21 February 2013
For ERC grantees only (top-up grant):
Proof of concept (ERC-2013-PoC)
10 January 2013
24 April and 3 October 2013
The new ERC calls 2013 are open
Update on ERC calls for proposals (2014):
18 April 2013 - Statement from the ERC Scientific Council
As the EU’s Seventh Research Framework Programme (FP7) will finish at the end of this year, the main ERC calls for proposals within FP7 are now closed. The next ERC calls will be made under the future programme, ‘Horizon 2020’, that will take over from FP7 for 2014 to 2020.
However, 'Horizon 2020’ has not yet been adopted. As is normally the case during the transition from one framework programme to another, the schedule for the next ERC calls (and ERC Work Programme) is very likely to differ from previous years.
The ERC Scientific Council has discussed the issue and, based on the current state of play, it can provide the following possible scenario on a purely indicative basis:
Publication of the provisional schedule for the new calls (ERC Work Programme 2014), late in 2013
Opening and submission deadlines of new ERC calls throughout 2014:
Opening and submission deadline for Starting grants; first and second quarter of 2014
Opening and submission deadline for Consolidator grants; second quarter of 2014
Opening and submission deadline for Advanced grants; fourth quarter of 2014
No further calls for Synergy grants in 2013 and 2014
Normal schedule for Proof of Concept grants (one call with two deadlines in 2014). Although no final decision has yet been taken by the EU, the ERC Scientific Council provides, without any commitment, this provisional information for the convenience of the scientific community
The ERC will do its utmost to make the transition as smooth as possible and provide the necessary continuity for the research community
No further information is available at this stage on the calendar, budget or rules of the next calls. Stay informed on the ERC website and the Participant Portal.
Pegasus Marie Curie Postdoctoral Fellowships for International Students in Belgium
Flanders(FWO), a research foundation invites application for its research funding scheme known as Pegasus. There are 6 calls in total, distributed over 3 years for both Pegasus short and long fellowships. The applications are open for international researchers at postdoctoral level in all scientific areas. The research is conducted at one of the Flemish universities. These Flemish universities included Ghent University (UGent), University of Antwerp (UA), Free University of Brussels (VUB), University of Hasselt (Hasselt University), Catholic University of Brussels (KUB). Each fellow will receive a bench fee of 4.000 €/year which can be used for the purchase of research equipment, research travels and other issues related to the fellowship.
Study Subject(s): Study can happen in one of the five scientific areas: Biological Sciences, Cultural Studies, Behavioural and Social Sciences, Medical Sciences, Science and Technology.
Eligibility: On the start date of the mandate, the candidate must have obtained a PhD in any scientific field. The Pegasus programme is open to all nationalities.
Scholarship Description: The goals of PEGASUS are:Excellent postdoctoral researchers to Flanders in order to contribute to the advancement of Flemish research.
Duration of award(s): Pegasus short term postdoctoral appointments are for one year at a Flemish university.
What does it cover? Every fellow receives a bench fee of 4.000 €/year. This can be used for the purchase of research equipment, research travels and other issues related to the fellowship. Medium size and large infrastructure, however, are to be provided by the host institution. Fellows have the opportunity to compete for an additional research grant up to 40,000 euro (covering research equipment and consumables), to the extent that they meet the criteria and regulations for FWO Research Grants.
The application form will be accessible online through the FWO e-portal.
Scholarship Application Deadline: For the short fellowships, there are 6 calls, distributed over 3 years.The remaining fellowships’ deadlines are: 01/02/2013, 01/05/2013, 01/02/2014 and 01/05/2014.(For the calls closing in February, the awarded fellowships will start on October 1 of the same year. For the calls closing in May, the awarded fellowships will start on January 1 of the next year.)
Image-guided Drug Delivery in Cancer (R01) (Funding Opportunity Announcement (FOA) Number PAR-13-185)
This Funding Opportunity Announcement (FOA) will support innovative research projects that are focused on image-guided drug delivery (IGDD), including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response. It will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.
Earliest Submission Date: May 19, 2013
Letter of Intent Due Date(s): Not Applicable
Application Due Date(s): June 19, 2013; November 19, 2013; June 19, 2014; November 19, 2014; June 19, 2015; November 19, 2015, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
The maximum period is 5 years.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Purpose: This Funding Opportunity Announcement (FOA) will support innovative research in image-guided drug delivery (IGDD) for cancer and other diseases. The overarching goals of this FOA are to support the development of quantitative in vivo imaging methods for IGDD across different physical and physiological resolution scales in order to interrogate tumor-drug interaction, study biodistribution, pharmacokinetics, pharmacodynamics and therapeutic response. Studies that are directed towards translation of IGDD technology to patient care will be considered appropriate for this FOA. This FOA will support research in development of integrated imaging-based platforms for multifunctional and multiplexed drug delivery systems for therapy.
2013 International Max Planck Research School for Molecular Cell Biology and Bioengineering, Germany
The International Max Planck Research School for Molecular Cell Biology and Bioengineering is offering a research position in Molecular Cell Biology and Bioengineering, for pursuing PhD degree level, in Germany. International applicants can apply for the research position.
Eligibility: Applicants must hold, or anticipate receiving before taking up thesis work, an undergraduate degree in one of the following disciplines: life sciences, natural sciences, engineering, medicine, computer science, physics, or applied mathematics. International applicants can apply for the research position. The degree level should allow the applicants to enter doctoral programs in their home country.
In general, a Masters degree or equivalent is required. Applicants holding an excellent BSc degree are also welcome to apply, given that independent research and a written thesis is part of the course of study. In that case, additional requirements to be completed during PhD thesis work will be defined on a case-to-case basis. Candidates holding a medical degree must have completed the course of study, including the exam equivalent to the German 2nd State Exam, before starting their PhD thesis.
Formal requirements: Applicants are required to provide relevant transcripts including the marks and degree certificates with the application. In case the course of study is ongoing, an official up-to-date preliminary transcript, including the marks obtained so far, is to be included.
Language requirements: The language of the Dresden International PhD Program is English. Proficiency in English is therefore required for participation, and applicants might be contacted by phone for assessment. However, formal proof of English proficiency (TOEFL, IELTS) is not requested.
Scholarship Description: PhD students of the International PhD Program will receive financial support for the duration of their thesis. Financial support is granted via one of two types of funding, (i) fellowships or (ii) working contracts. The type of funding a student receives is dependent upon the specific source of funding for each student, and is defined by the available resources of the hosting group leader and the hosting organization. Fellowships are tax free and do not include any contributions to social insurances. Health insurance is compulsory and individual arrangements are to be made by the fellow (with the help of the PhD program office). Individual arrangements for pension schemes are optional. Contracts are taxed, and contributions to health insurance, pension scheme and social benefits are included and automatically deducted from the income. The monthly fellowship rate corresponds to up to 1365 Euro plus 103 Euro additional allowance per month. Contracts are according to 50% to 65% TV-L E13 respectively TvöD E13 (German tariff for employees in civil service). Irrespective of the source of funding, the initial net income (after deduction of compulsory insurances respectively tax and contribution to social insurances) is approximately 1000 Euro per month at a minimum. As a rule, financial support within the International PhD Program terminates with the final exam of the doctorate proceedings.
The monthly fellowship rate corresponds to up to 1365 Euro plus 103 Euro additional allowance per month. Irrespective of the source of funding, the initial net income (after deduction of compulsory insurances respectively tax and contribution to social insurances) is approximately 1000 Euro per month at a minimum.
Detection of Pathogen-Induced Cancer (DPIC) (R01) (Funding Opportunity Announcement (FOA) Number PAR-13-190)
This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to encourage research projects which focus on the interactions of carcinogenic pathogens with the human microbiome and the host for the detection of pathogen-induced cancer (DPIC). This FOA encourages research to assess molecular signatures associated with risk and early detection of pathogen-induced cancer and chronic inflammation associated with progression to invasive cancer.
Earliest Submission Date: June 10, 2013
Letter of Intent Due Date(s): 30 days before the application due date
Application Due Date(s): July 10, 2013; December 11, 2013; July 10, 2014; December 11, 2014; July 10, 2015; December 11, 2015, by 5:00 PM local time of applicant organization.
The maximum project period is 5 years.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Background and Rationale: Microbial Pathogens and Carcinogenesis. More than 20% of cancers worldwide are known to be associated with microbial pathogens, including bacteria and viruses. Numerous epidemiological studies have reported an increased risk of precancerous lesions and cancers associated with pathogens. It is widely believed that perturbations in the composition of the human microbiota may increase the risk of, or cause, cancer. This has led to the hypothesis that the microbial ecosystem and interactions between infectious pathogens and host cells play a critical role in modulating cancer-related pathways. Systemic factors, such as the microbiome, inflammatory status, and other microbial-related factors might also modulate progression of precancerous lesions to aggressive cancer.
The Wellcome Trust Masters Fellowships in Public Health and Tropical Medicine
This scheme strengthens scientific research capacity in low- and middle-income countries, by providing support for junior researchers to gain research experience and high-quality research training at Masters degree level.
Research projects should be aimed at understanding and controlling diseases (either human or animal) of relevance to local, national or global health. This can include laboratory based molecular analysis of field or clinical samples, but projects focused solely on studies in vitro or using animal models will not normally be considered under this scheme.
We are particularly interested in requests for research training support in the social sciences, demography, health economics, medical statistics and vector biology.
This fellowship is part of a series of career awards aimed at building sustainable capacity in areas of research that have the potential for increasing health benefits for people and their livestock in low- and middle-income countries.
The Wellcome Trust and the Association of Physicians of Great Britain and Ireland have established a joint Wellcome Trust- Association of Physicians of Great Britain and Ireland Masters Fellowship. Two joint awards per annum will be made, in addition to the Wellcome Trust Masters Fellowships. These will be considered during the selection process for Wellcome Trust Master's Fellowships - no separate application is required.
This fellowship normally provides up to 30 months' support. A period of 12 months should normally be dedicated to undertaking a taught Masters course at a recognised centre of excellence, combined with up to 18 months to undertake a research project.
While undertaking a Masters course, fellows will receive a stipend in accordance with the cost of living in the country in which he/she will be studying; travel costs and support for approved tuition fees. Masters training by distance learning is acceptable.
Masters course fees will be paid according to the rate charged by the training institution.
A salary is provided for the period of the research project. Project-dedicated research expenses (consumables, small items of equipment, collaborative travel and support to attend scientific meetings, fieldwork and data collection) are also provided. Overseas allowances will be provided where appropriate. Contributions to other costs of the project that are directly incurred by the overseas institution may also be provided.
Research-dedicated costs (excluding salary/stipend costs) should not exceed £20 000 per annum.
If the fellow is already in receipt of a salary from the host institution, the host institution may use this salary to pay for a replacement member of staff while the Trust provides the fellow's salary/stipend for the duration of the fellowship. It is not expected that the fellow would receive a salary in addition to the one provided by the Trust.
Please note that the Trust is no longer accepting applications from current fellows who wish to extend their grants in order to undertake a PhD. The eligibility criteria for the Training Fellowship in Public Health and Tropical Medicine now includes applicants who have a clinical, basic or Master’s degree and some initial research experience, with the expectation that they will register for a PhD.
We will consider applications that fall within the Public Health and Tropical Medicine Interview Committee remit.
You should be:
a national or legal resident of a low- and middle-income country, and hold a first degree in subject relevant to tropical medicine or public health (clinical or non-clinical)
at an early stage in your career, with limited research experience, but have a demonstrated interest in or aptitude for research.
Applications are considered twice a year.
Next application deadline: 1 August 2013 (not 1 March 2013 as previously announced) Final decision by Interview Committee: November 2013 Next application deadline: 10 December 2013 Final decision by Interview Committee: March 2014
Late applications will not be considered.
Fellowships must be taken up within one year of award.
[Source: Scholarship-Positions.com and The Wellcome Trust]
2013 TWAS-CAS Fellowships for Visiting Scholars in China (Natural Sciences)
The Chinese Academy of Sciences (CAS) and TWAS offer fifteen Visiting Fellowships. The fellowships are offered to all students from Developing Countries (other than China). These Visiting Scholar Fellowships are offered in the field of natural sciences and are tenable for minimum period of one to a maximum of three months at the research institutions of the Chinese Academy of Sciences. The applicant applying for the fellowship must be a maximum age of 55 years on 31 December of the application year.
Eligibility - applicants for these fellowships must meet the following criteria:
be a maximum age of 55 years on 31 December of the application year
be nationals of a developing country (other than China)
must not hold any visa for temporary or permanent residency in China or any developed country
hold a PhD degree in a field of the natural sciences and a regular research assignment with at least five years of postdoctoral research experience
be accepted at a CAS-listed institution participating in the scheme and provide an official acceptance letter from the host institution (see sample Acceptance Letter, page 3) to this effect
provide evidence of proficiency in English or Chinese
The fellowship is open for students from the following countries: The students of Afghanistan, Gambia, Mozambique, Bangladesh, The Guinea, Myanmar, Benin, Guinea-Bisau, Nepal, Burkina Faso, Haiti, Niger, Burundi, Kenya, Rwanda, Cambodia, Korea, Dem Rep., Sierra Leone, Central African Republic, Kyrgyz Republic, Somalia, Liberia, Tajikistan, Comoros, Madagascar, Tanzania, Malawi, Togo, Congo, Dem. Rep, Eritrea, Mali, Uganda, Ethiopia, Mauritania, Zimbabwe, Albania, Indonesia, Samoa, Armenia, India, São Tomé and Principe, Belize, Iraq, Senegal, Bhutan, Kiribati, Solomon Islands, Bolivia, Kosovo, South Sudan, Cameroon, Lao PDR, Sri Lanka, Cape Verde, Lesotho, Sudan, Congo, Rep., Marshall Islands, Swaziland, Côte d’Ivoire, Micronesia, Fed. Sts., Syrian Arab Republic, Djibouti, Moldova, Timor-Leste, Egypt, Arab Rep., Mongolia, Tonga, El Salvador, Morocco, Ukraine, Fiji, Nicaragua, Uzbekistan, Georgia, Nigeria, Vanuatu, Ghana, Pakistan, Vietnam, Guatemala, Papua New Guinea, West Bank and Gaza, Guyana, Paraguay, Yemen, Rep., Honduras, Philippines,Zambia, Angola, Ecuador, Palau, Algeria, Gabon, Panama, American Samoa, Grenada, Peru, Antigua and Barbuda, Iran, Islamic Rep., Romania, Argentina, Jamaica, Russian Federation, Azerbaijan, Jordan, Serbia, Belarus, Kazakhstan, Seychelles, Bosnia and Herzegovina, Latvia, South Africa, Botswana, Lebanon, St. Lucia, Brazil, Libya, St. Vincent and the Grenadines, Bulgaria, Lithuania, Suriname, Chile, Macedonia, FYR, Thailand, Malaysia, Tunisia, Colombia, Maldives, Turkey, Costa Rica, Mauritius, Turkmenistan, Cuba, Mexico, Tuvalu, Dominica, Montenegro, Uruguay can apply for the fellowship.
Scholarship Description: TWAS-CAS Visiting Scholar Fellowships in natural sciences are tenable for minimum period of one to a maximum of three months at the research institutions of the Chinese Academy of Sciences. Eligible CAS institutions: More than 80 CAS institutes in China participate in this Fellowship programme. The language of instruction is English. International travel (return economy class by the shortest route) and visa expenses will be covered by TWAS. CAS will provide a standard monthly allowance which should be used to cover living costs, such as accommodation, food and health insurance. Only emergency medical aid will be available, if necessary. The monthly stipend will not be convertible into foreign currency. Applicants must be affiliated with a university or research centre in their home country. Applicants already on site in the host country are not eligible. Applicants must provide evidence that they will return to their home country upon completion of their Fellowships.
15 fellowships are awarded, tenable for a minimum period of one to a maximum of three months at the research institutions.
The Elsevier Awards for Early-Career Women Scientists in the Developing World - Chemical Sciences
The Awards recognize the research excellence of women scientists working and living in Africa, the Middle East, Asia, Latin America and the Caribbean. Deadline for receiving nominations for the 2014 Awards is 15 September 2013.
The Elsevier Awards for Early-Career Women Scientists in the Developing World were launched in 2012 by The Elsevier Foundation, TWAS and OWSD to celebrate the achievements of women scientists in the early stages of their careers, with the aim of creating role models for other women to follow, a step that is critical for retaining top talent and building a stronger research culture in developing countries.
Five Awards will be awarded annually, one each to a female scientist from one of the five regions of the world: Latin America and the Caribbean; the Arab region; Sub-Saharan Africa; Central and South Asia; and East and South-East Asia and the Pacific. The five region-specific annual Awards will rotate between the life sciences, chemical sciences and physical, mathematical and engineering sciences. In 2014, the five Awards will be given in the chemical sciences.
The five winning scientists of the 2014 edition will be celebrated for their research excellence, and receive a cash prize of USD5,000 in addition to a year’s complimentary access to ScienceDirect and all-expenses-paid attendance at the Annual Meeting of the American Association for the Advancement of Science (AAAS) in February 2014 in Chicago, IL, USA, where the awards ceremony will take place. The winners will also be invited to attend international events pertaining to OWSD and TWAS.
Eligibility: Candidates must be female early-career scientists (within ten years of earning their PhD degree). At nomination, candidates must have lived and worked for at least three years in one of the countries listed in the nomination form.
Selection: The selection process will be administered by OWSD and TWAS. The assessment will be based on achievements in the field, with particular attention paid to the nominees’ publications in international peer-reviewed journals. Winners will be informed of their selection in November/December 2013.
Nominations: Nominations are invited from OWSD members, TWAS members, national science academies, national research councils and senior academics (heads of departments, heads of universities) both in developing and developed countries. Self-nominations, or nominations by selection committee members, are not accepted. Nominations need to be made on the nomination form and be signed by the nominator; they must include the candidate's curriculum vitae and full list of publications; and be accompanied by three reference letters. Nominations must reach the OWSD Secretariat by 15 September 2013.
University of Antwerp International Health Unit (IHU): International Course in Epidemiology, Biostatistics & Qualitative Research Methods (EBQ)
This course offers a profound training of 6 weeks on the basic principles and methods of epidemiology. An in-depth study of medical statistics with appropriate statistical methods will be integrated with the main epidemiological content. Basic principles of qualitative methods will be explained. Introductory lectures on systematic reviews, health economics and cost-effectiveness are programmed. Throughout the whole course, each participant will have the opportunity to work with his/her own data set under the guidance of an experienced tutor (one to one).
This course offers a broad ‘toolbox’ of research methodologies to enable a scientist to answer a research question with the correct research design (qualitative or quantitative), analyse the data and present results. Thus, it has the comparative advantage that it may replace a series of separate multiple short courses, hence it is a cost-effective and comprehensive alternative.
The closing date for applications is 1st June 2013.
EFIS-EJI Ruggero Ceppellini Advanced School of Immunology: Title: Advanced EFIS-EJJI course on: Novel vaccination strategies against the three major killers
The course—held 16–20 October 2013, Castellammare di Stabia, (Naples), Italy—will review aspects of the immunology of Malaria, Tuberculosis, and HIV/AIDS which are important for vaccine and biomarker development, discuss how host protective immunity can translate into the design and development of novel vaccines, consider how biomarkers support vaccine development, and examine the vaccines currently under clinical trial. The official language is English. The number of participants is limited to 75.
Cost and Bursaries: Early registration fee is € 550.00 (until 1 September, 2013) and includes course material, lunches, coffee breaks, welcome buffet dinner and a guided tour of Roman ruins. An additional €100 will be charged for late registration. Several bursaries are available for registration fee and/or hotel + dinners from funding provided by EFIS-EJI. Additional funding has been requested from the Bill & Melinda Gates Foundation specifically for African applicants for travel expenses, registration fee, hotel and dinners.
6th Pan-African Malaria Conference 6-11 October 2013 in Durban, South Africa
Moving Towards Malaria Elimination: Investing in Research and Control
The Multilateral Initiative on Malaria Secretariat (MIMSec) at the Biotechnology Centre of the University of Yaounde I, and the South African Medical Research Council (SA MRC) announces the 6th Pan African Malaria Conference of the Multilateral Initiative on Malaria (MIM). The 6th MIM Conference, now open for applications and to members of the media, will be held from 6-11 October 2013 in Durban, South Africa.
Every three to four years, the Multilateral Initiative on Malaria, organises the MIM Pan African Malaria Conference. Beginning in Dakar in 1997; Durban, South Africa 1999, Arusha, Tanzania 2002; Yaounde, Cameroon, 2005, and lately in Nairobi, Kenya 2009, the MIM conferences bring together over 2000 malaria researchers from across Africa and around the world to consider malaria research advances, how to more effectively employ or develop malaria-control strategies, and how to strengthen malaria research training activities. The conference also provides a unique opportunity for scientists, development agencies and health agencies to meet and discuss research required to underpin the control of malaria and build research capacity in Africa.
MIM is an international alliance of research and public health agencies and African scientists established in 1997 in Dakar, Senegal, at the first Pan-African Malaria Conference. MIM's objectives are to stimulate and support collaborative research to address the needs of public health programs in malaria-endemic countries and to strengthen research capacity in malaria-endemic countries. The South African Medical Research Council, which won the bid to host the conference and the current MIM Secretariat at the Biotechnology Centre of the University of Yaounde I, will organized the conference on behalf of the MIM partners.
With increasing access to life-saving malaria prevention and control measures, the number of estimated malaria cases and deaths are declining in areas at risk of malaria including in endemic countries in sub-Saharan Africa. Although in 2010, malaria was the cause of an estimated 655,000 deaths worldwide, this figure actually represents a 5 per cent decrease from the 781,000 in 2009. Intensified research, development of new tools, increase international commitment and funding for malaria control activities have undoubtedly played a large part in this success. There is great optimism about controlling malaria to the point where it is no longer a public health problem. This represents a major paradigm shift especially as it would have been considered impossible a few years back.
However, despite these gains and advancements, there are worrisome signs: environmental changes, decrease funding for malaria control and research, resistance to insecticides and drugs and re-emergence of malaria in areas that had reported a decline in previous years. Such concerns if not contained and effectively managed will jeopardize the current commitment to eliminate malaria providing grounds for serious epidemics in people of all ages, with rapid loss of the gains accrued. Securing and sustaining funding to finance malaria control, global research and the development of new tools is of paramount importance in achieving universal coverage and moving towards elimination.
First Call: November 15, 2012
Second Call: March 30, 2013
End of Abstracts Submission: June 30, 2013
Travel Awards: July 30, 2013
Exhibition Registration Deadline: August 30, 2013
Delegate Registration deadline: September 5, 2013 Deadline September 5, 2013
Further developments about the conference will be disseminated progressively through our list serve and partners. For further details about attending the MIM conference, please contact: E-mail: email@example.com
4th International Conference on Stem Cells and Cancer (ICSCC-2013): Proliferation, Differentiation and Apoptosis
19th to 22nd October 2013
Mumbai, Maharashtra, India
Covers basic/applied research on proliferation, differentiation & apoptosis of stem & cancer cells, stem cell therapy, clinical trials on stem cells, cancer diagnostics, anti-cancer drugs, cancer therapeutics, HSC, iPSC, MSC, cancer stem cells etc.
Organized by: International Centre for Stem Cells, Cancer and Biotechnology (ICSCCB), Pune, India.
20–23 October 2013, Seventh EDCTP Forum in Dakar, Senegal
The European & Developing Countries Clinical Trials Partnership (EDCTP) will hold its Seventh Forum in Dakar, Senegal on the 20-23 October 2013. EDCTP stakeholders are requested to save the dates. The Seventh Forum programme framework will be published in January 2013.
The biennial EDCTP Forum provides an international platform for the presentation and discussion of frontier research for everyone involved in combating the three main poverty-related diseases (HIV/AIDS, tuberculosis and malaria) and the appropriate capacity development and networking activities. The Forum has established itself as a valuable opportunity to establish and reinforce cooperation and synergy among EDCTP stakeholders at various levels including scientific, policy, funding and political interactions. Scientists involved in EDCTP-funded projects are particularly encouraged to use this opportunity to share new developments and results from their projects.
The programme: The Seventh Forum programme framework will be published in January 2013. The programme will include speakers from the scientific, policy, ethics and regulatory as well as political fields. The focus will be on advances in research, capacity development, networking and agenda setting for clinical research on HIV/AIDS, tuberculosis and malaria. Priority will be given to EDCTP-funded projects to share their results.
Venue and accommodation: The Forum will be held at the King Fahd Palace Hotel in Dakar, Senegal. Information regarding accommodation for the delegates and the various options will be published on the Forum website.
Participation: EDCTP will invite keynote speakers for the plenary sessions. In addition, abstracts will be invited for oral and poster presentations to be selected based on scientific merit. Presentations on EDCTP-funded projects are particularly encouraged. EDCTP will publish a call for abstracts in January 2013. A selection of applicants with well-rated abstracts especially from sub-Saharan Africa working on EDCTP-funded projects will be awarded scholarships. Details on submission of abstracts and application for scholarships will be published with the call for abstracts.
Sponsorship opportunities: The Seventh EDCTP forum will offer organisations various possibilities to support the meeting and raise their visibility. Information on sponsorship packages and how to apply will be soon available on the website.
Forum updates and website: The Seventh EDCTP Forum website will be launched in January 2013 and will communicate updates on the programme and on opportunities to join the Forum.
France South Africa Seasons 2012 & 2013
On 10 May 2012 the France South Africa Seasons 2012 & 2013 were officially announced to the South Africa media in Johannesburg. The project was unveiled and some of the programme highlights were showcased to the assembled guests. For several years France has been engaged in a series of reciprocal Seasons with its key international partners (China, Japan, India, Turkey, Russia and Brazil among others). With South Africa, this will be the first time that a sub-Saharan country is involved in the Seasons with France. The goal of these Seasons is to improve mutual understanding and contribute to the diversification of France’s image in South Africa and South Africa’s image in France by emphasising the modernity and values that the two countries share. The department for scientific cooperation is thus pleased to address you a copy of our special edition of the SciTech Watch newsletter, presenting to you a selection of S&T projects to be showcased during the French Season in South Africa.
[Source: Bianca Naudé, Embassy of France, Pretoria/NRF]
Draft Strategic Business Plan for the second phase of EDCTP (EDCTP-II)
NRF Support Desk regarding updating of CVs
The NRF is opening several calls for submitting applications for funding. We therefore want to remind applicants to please update or complete their CVs on NRF Online as well. This should be done whether the application gets submitted electronically on the NRF systems (NRF Interim or NRF Online) or in hard copy format (e-mailed as a PDF document). Applications will unfortunately not be considered if the CV has not be completed or updated. Contact: Bettie de Beer, Support Desk Co-ordinator, GMSA:Support Desk, tel 012 481 4034, fax 086 623 2665, BETTIE@nrf.ac.za
NRF re Acknowledgement of the National Research Foundation in research outputs accruing from NRF support
Please use “National Research Foundation (NRF) of South Africa” in these acknowledgements.
The ISI Web of Knowledge and specifically the Web of Science provide us with the ability to comprehensively analyse research publications. This capability allows the NRF to benchmark the performance of the NRF and the South African Science system as a whole. The funding agency analysis assists the NRF to measure its own performance in relation to other agencies. It also gives an indication of what is being funded by the various agencies both nationally and internationally.
As with every information system the quality and completeness of information generated are directly related to the quality and completeness of the data that are entered. While analysing the 2010 publications which involved South African authors we discovered that 55% of the 9 325 records did not contain sponsor information. A further analysis of the 55% revealed several authors who received grants from the NRF did not acknowledge the NRF. It is for this reason that we request all NRF Grantholders as well as the entire research community to acknowledge the NRF (if you receive NRF support) as well as other sponsors. This is critically important as the information allows the NRF to present an evidence-based case to government for additional resources for research. We trust that you will honour this request.
Global Forum and COHRED merged
In March 2011 the Global Forum for Health Research and COHRED were merged, combining the best of both organizations. The merged structure for the first time creates one platform for dialogue and policy shaping between the global health players and their country counterparts. As COHRED Board Chair Cheikh Mbacké has said, " The new organization will provide a significant added value to our activities in terms of bringing research and technical knowledge to the different players in the field of research and innovation for health." The two organizations are currently working under the name of The COHRED Group
[Source: The COHRED Group]
The Africa Portal (http://www.africaportal.org/) is an online knowledge resource offering researchers and opinion leaders a forum to share their insights on Africa and publish their work on pressing areas of concern to policymakers and the public. It aims to fill the gap in accessibility to research and information on policy issues on the continent.
A key feature of the Africa Portal is the online library collection, holding over 2,500 books, journals and digital documents relating to African policy issues. The entire online repository is open access and available for free full-text download. A portion of the digital documents housed in the library have been digitised for the first time as an undertaking of the Africa Portal project.
The project is a collaborative undertaking between The South African Institute of International Affairs (SAIIA), the Centre for International Governance Innovation in Canada, and Makerere University in Uganda.